The Latest Breaking News from Obesity

The stronger Wegovy dose could see more than 20 per cent weight loss in patients with obesity

Obesity in children has become a common issue these days. With the change in lifestyle and parenting styles unhealthy amounts of weight gain is seen in many children. This can caused serious health issues at a very young age. Parents need to be mindful about their children’s habits in order…

In today’s newsletter: A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse – leading to questions about long-term impacts and solutions

Weight-loss injections, like Wegovy and Mounjaro, have been hailed as gamechangers. In clinical trials, people lost an average of 15%-20% of their body weight – results that seemed almost miraculous compared to traditional diet and exercise programmes.

Many taking weight loss drugs could be at risk of ‘replacing one set of health problems with another’, academics warned

The vast majority of people taking Wegovy and Mounjaro pay privately owing to restrictions on who can access the medicines via the NHS.

For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises…

A loophole in the ban means companies can still advertise brand names, which experts argue leaves children no better protected

In today’s newsletter: As new rules ban TV and online ads for high-fat, salt and sugar products​, the curbing of junk food marketing has found cross-party support